Rising Sexual Health Awareness To Drive Genital Herpes Market Growth Driver: A Major Catalyst in the Evolution of the Genital Herpes Market in 2025

How Is the Genital Herpes Market Projected to Grow, and What Is Its Market Size?
The market for genital herpes has significantly expanded in the latest years. This growth is expected to climb from $2.19 billion in 2024 to $2.34 billion during 2025, with a compound annual growth rate (CAGR) of 7.1%. The expansion in the past years is attributed to aspects such as higher awareness and diagnostic measures, advanced breakthroughs in treatment modes, facilitated access to healthcare facilities, public health movements, and socio-demographic variables.

The market for genital herpes is anticipated to experience robust expansion in the coming years, reaching an estimated value of $3.05 billion in 2029 with a compounded annual growth rate (CAGR) of 6.8%. Factors prompting growth during this forecasted period include an increased educational awareness of the disease, advances in treatments and vaccines, higher occurrence rates, digital healthcare technologies, widened access to healthcare, and the proliferation of STI awareness campaigns. Key future trends include the embracing of telemedicine, advancements in antiviral therapy, research and development into vaccines, increased access to health services, improved public health campaigns, and the incorporation of artificial intelligence and data analytics.

What Factors Are Fueling Growth in the Genital Herpes Market?
An increasing emphasis on sexual health is predicted to stimulate expansion in the genital herpes market. This heightened attention to sexual health originates from the growing acknowledgement of its crucial importance in overall wellbeing and lifestyle quality. The primary services for genital herpes relating to sexual health include diagnosis, treatment, counseling, and persistent management to help individuals handle outbreaks, prevent transmission, and tackle emotional and relational issues related to the condition. For instance, data from the Local Government Association, a national member organization based in the UK, shows that in January 2024, the demand for sexual health services saw an upsurge, with nearly 4.5 million consultations held in 2022, indicating a 33% increase. Also, diagnostic testing activity was substantial, with 2.2 million tests done in 2022, translating to a 13% growth compared to 2021. Thus, the escalating emphasis on sexual health is anticipated to propel the genital herpes market's growth.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17161&type=smp

Who Are the Major Industry Players Fueling Genital Herpes Market Expansion?
Major companies operating in the genital herpes market are Pfizer Inc, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, BioNTech SE, Viatris Inc, Teva Pharmaceuticals Inc, Sandoz Inc, Fresenius Kabi AG, Valeant Pharmaceuticals International Inc, Sun Pharmaceutical Industries Ltd, Bausch + Lomb Corporation, Dr. Reddy's Laboratories Ltd, Apotex Inc, Zydus Group, Genocea Biosciences Inc, Glenmark Pharmaceuticals Inc, Maruho Co Ltd, Romark Laboratories, Eurocine Vaccines AB, Vical Incorporated

Which Key Developments Are Influencing the Genital Herpes Market?
Numerous leading firms in the genital herpes market are utilizing strategic alliances to amplify their technological prowess and market accessibility. Such a tactic usually involves two or more organizations combining their assets, skills, and efforts to meet shared targets or mandates. For example, in June 2022, Eurocine Vaccines AB, a biotechnology company from Sweden that focuses on herpes disease treatment therapies and products, formed a research and partnership contract with Redbiotec AG, a Swiss biotech firm. The deal endows them with exclusive international rights for the creation, production, and selling of vaccine candidates that target Herpes Simplex Virus Type 2 (HSV-2). The contract envelops both mRNA- and protein-based technologies, including related paperwork and patents pertaining to the HSV-2 field. Eurocine Vaccines is in charge of and finances all actions linked to development, manufacturing, and commercialization until a subsequent licensing agreement with an external party is secured.

How Is the Segmentation of the Genital Herpes Market Defined?
The genital herpes market covered in this report is segmented -

1) By Type: Diagnosis, Treatment
2) By Route Of Administration: Oral, Injectable, Topical
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channel

Subsegments:
1) By Diagnosis: Polymerase Chain Reaction (PCR) Tests, Viral Culture Tests, Blood Antibody Tests (Serology), Antigen Detection Tests, Point-Of-Care Rapid Tests
2) By Treatment: Antiviral Medications, Acyclovir, Valacyclovir, Famciclovir, Topical Treatments, Acyclovir Cream, Docosanol Cream, Preventive Therapies, Suppressive Therapy, Prophylactic Vaccines (Under Development), Pain Management Medications, Analgesics, Topical Anesthetics

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

What Is the Leading Region in the Genital Herpes Market?
North America was the largest region in the genital herpes market in 2023. The regions covered in the genital herpes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Genital Herpes Global Market Report?

- Market Size Analysis: Analyze the Genital Herpes Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Genital Herpes Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Genital Herpes Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Genital Herpes Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17161

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.